Nogueira F
Novel potent metallocenes against liver stage malaria
- Autores: Cabrita E, da Cruz FP, Do Rosário VE, Gomes P, Gut J, Matos J, Moreira R, Nogueira F, Prudencio M, Rosenthal PJ
- Ano de Publicação: 2012
- Journal: Antimicrobial Agents and Chemotherapy
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Novel+potent+metallocenes+against+liver+stage+malaria.
Novel conjugates of the antimalarial drug primaquine (compound 1) with ferrocene, named primacenes, have been synthesized and screened for their activities against blood stage and liver stage malaria in vitro and host-vector transmission in vivo.
Ler mais
N-Cinnamoylation of Antimalarial Classics: Effects of Using Acyl Groups Other than Cinnamoyl toward Dual-Stage Antimalarials
- Autores: Gomes A, Gomes P, Lobo L, Machado M, Nogueira F, Prudencio M, Teixeira C
- Ano de Publicação: 2015
- Journal: Chemmedchem
- Link: http://www.ncbi.nlm.nih.gov/pubmed/26038181
In a follow-up study to our reports of N-cinnamoylated chloroquine and quinacrine analogues as promising dual-stage antimalarial leads with high in vitro potency against both blood-stage Plasmodium falciparum and liver-stage Plasmodium berghei, we decided to investigate the effect of replacing the cinnamoyl moiety with other acyl groups.
Ler mais
N10,N11-di-alkylamine indolo 3,2-b quinolines as hemozoin inhibitors: Design, synthesis and antiplasmodial activity
- Autores: Coelho L, Egan TJ, Figueiras M, Gut J, Lavrado J, Moreira R, Nogueira F, Paulo A, Rosenthal PJ, Santos SA, Wicht KJ
- Ano de Publicação: 2015
- Journal: Bioorganic & Medicinal Chemistry
- Link: http://www.ncbi.nlm.nih.gov/pubmed/25725608
We recently reported that potent N10,O11-bis-alkylamine indolo[3,2-b]quinoline antimalarials act as hemozoin (Hz) growth inhibitors.
Ler mais
Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues
- Autores: Barros MT, Faisca Phillips AM, Murtinheira F, Nogueira F
- Ano de Publicação: 2015
- Journal: Bioorganic & Medicinal Chemistry Letters
- Link: http://www.ncbi.nlm.nih.gov/pubmed/25881827
The continuous development of drug resistance by Plasmodium falciparum, the agent responsible for the most severe forms of malaria, creates the need for the development of novel drugs to fight this disease.
Ler mais
Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs
- Autores: Arez AP, Dias F, Escobar C, Fernandes N, Lobo E, Lobo L, Nogueira F, Pateira S, Teodósio R, Varandas L
- Ano de Publicação: 2015
- Journal: PLoS One
- Link: http://www.ncbi.nlm.nih.gov/pubmed/25789669
We report the presence of SNPs in Plasmodium falciparum K13-propeller gene in two African countries, Angola and Mozambique, where malaria is a serious public health problem.
Ler mais
Plasmodium vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon
- Autores: Alecrim MGC, Brasil LW, Costa MRF, Lacerda MVG, Marques MM, Monteiro WM, Nascimento MTS, Nogueira F, Reyes-Lecca RC, Santana Filho FS, Silveira H, Vieira JLF
- Ano de Publicação: 2014
- Journal: Antimicrobial Agents and Chemotherapy
- Link: http://aac.asm.org/content/early/2013/10/22/AAC.02279-12
In Latin America, data on chloroquine (CQ)-resistant Plasmodium vivax is limited, even with the current research efforts to sustain an efficient malaria control program in all these endemic countries, where malaria still is a major public health issue. This study estimated in vivo CQ-resistance in uncomplicated patients with P. vivax in use of CQ and primaquine simultaneously, in the Brazilian Amazon. From a total of 135 enrolled subjects, who accomplished the 28-day follow-up, parasitological failure was observed in 7 (5.2%) patients, in which plasmatic CQ and desethylchloroquine (DCQ) concentrations were above 100ng/dL.
Ler mais
Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy
- Autores: de Sousa B, Fernandes N, Figueiredo P, Lobo E, Lobo L, Nogueira F, Pateira S, Rosa S
- Ano de Publicação: 2014
- Journal: Malaria Journal
- Link: http://www.malariajournal.com/content/13/1/300
Mozambique implemented artemisinin-based combinations therapy (ACT) using artemether-lumefantrine (AL) as the first-line treatment for uncomplicated malaria in 2009. AL remains highly efficacious, but widespread use may soon facilitate emergence of artemisinin tolerance/resistance. The prevalence of pfmdr1 different alleles in Maputo and Mozambique is not known, either after or before the introduction of ACT. Pfmdr1 molecular markers related to Plasmodium falciparum susceptibility were analysed before and after transition to ACT.
Ler mais
N-Cinnamoylation of Antimalarial Classics: Quinacrine Analogues with Decreased Toxicity and Dual-Stage Activity
- Autores: Albuquerque I, Gomes A, Gomes P, Machado M, Nogueira F, Perez B, Prudencio M, Teixeira C
- Ano de Publicação: 2014
- Journal: Chemmedchem
- Link: http://www.ncbi.nlm.nih.gov/pubmed/24474655
Plasmodium falciparum, the causative agent of the most lethal form of malaria, is becoming increasingly resistant to most available drugs. A convenient approach to combat parasite resistance is the development of analogues of classical antimalarial agents, appropriately modified in order to restore their relevance in antimalarial chemotherapy. Following this line of thought, the design, synthesis and in vitro evaluation of N-cinnamoylated quinacrine surrogates, 9-(N-cinnamoylaminobutyl)-amino-6-chloro-2-methoxyacridines, is reported.
Ler mais
Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone
- Autores: Borrego MJ, Castro R, Damiao V, Farinha C, Florindo C, Martins-Pereira F, Nogueira F, Rodrigues F, Santos-Sanches I, Silvestre I
- Ano de Publicação: 2014
- Journal: Eurosurveillance
- Link: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20825
This study presents the serotype distribution and the antibiotic resistance profile of 953 colonising group B Streptococcus (GBS) recovered from women of child bearing age (15 to 49 years) between 2005 and 2012 in the Lisbon and Tagus Valley region, Portugal. Overall, serotypes Ia, II, III, and V were the most common, accounting 752 of the 953 isolates (about 80%).
Ler mais